Outcomes of a Multicenter Training Program in Laparoscopic Pancreatoduodenectomy (LAELAPS-2).


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 4 11 2017
medline: 15 11 2019
entrez: 4 11 2017
Statut: ppublish

Résumé

The aim of the study was to assess feasibility and outcomes of a multicenter training program in laparoscopic pancreatoduodenectomy (LPD). Whereas expert centers have reported promising outcomes of LPD, nationwide analyses have raised concerns on its safety, especially during the learning curve. Multicenter, structured LPD training programs reporting outcomes including the first procedures are lacking. No LPD had been performed in the Netherlands before this study. During 2014-2016, 8 surgeons from 4 high-volume centers completed the Longitudinal Assessment and Realization of Laparoscopic Pancreatic Surgery (LAELAPS-2) training program in LPD, including detailed technique description, video training, and proctoring. In all centers, LPD was performed by 2 surgeons with extensive experience in pancreatic and laparoscopic surgery. Outcomes of all LPDs were prospectively collected. In total, 114 patients underwent LPD. Median pancreatic duct diameter was 3 mm [interquartile range (IQR = 2-4)] and pancreatic texture was soft in 74% of patients. The conversion rate was 11% (n = 12), median blood loss 350 mL (IQR = 200-700), and operative time 375 minutes (IQR = 320-431). Grade B/C postoperative pancreatic fistula occurred in 34% of patients, requiring catheter drainage in 22% and re-operation in 2%. A Clavien-Dindo grade ≥ III complication occurred in 43% of patients. Median length of hospital stay was 15 days (IQR = 9-25). Overall, 30-day and 90-day mortality were both 3.5%. Outcomes were similar for the first and second part of procedures. This LPD training program was feasible and ensured acceptable outcomes during the learning curve in all centers. Future studies should determine whether such a training program is applicable in other settings and assess the added value of LPD.

Sections du résumé

OBJECTIVE
The aim of the study was to assess feasibility and outcomes of a multicenter training program in laparoscopic pancreatoduodenectomy (LPD).
BACKGROUND
Whereas expert centers have reported promising outcomes of LPD, nationwide analyses have raised concerns on its safety, especially during the learning curve. Multicenter, structured LPD training programs reporting outcomes including the first procedures are lacking. No LPD had been performed in the Netherlands before this study.
METHODS
During 2014-2016, 8 surgeons from 4 high-volume centers completed the Longitudinal Assessment and Realization of Laparoscopic Pancreatic Surgery (LAELAPS-2) training program in LPD, including detailed technique description, video training, and proctoring. In all centers, LPD was performed by 2 surgeons with extensive experience in pancreatic and laparoscopic surgery. Outcomes of all LPDs were prospectively collected.
RESULTS
In total, 114 patients underwent LPD. Median pancreatic duct diameter was 3 mm [interquartile range (IQR = 2-4)] and pancreatic texture was soft in 74% of patients. The conversion rate was 11% (n = 12), median blood loss 350 mL (IQR = 200-700), and operative time 375 minutes (IQR = 320-431). Grade B/C postoperative pancreatic fistula occurred in 34% of patients, requiring catheter drainage in 22% and re-operation in 2%. A Clavien-Dindo grade ≥ III complication occurred in 43% of patients. Median length of hospital stay was 15 days (IQR = 9-25). Overall, 30-day and 90-day mortality were both 3.5%. Outcomes were similar for the first and second part of procedures.
CONCLUSIONS
This LPD training program was feasible and ensured acceptable outcomes during the learning curve in all centers. Future studies should determine whether such a training program is applicable in other settings and assess the added value of LPD.

Identifiants

pubmed: 29099400
doi: 10.1097/SLA.0000000000002563
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-350

Commentaires et corrections

Type : CommentIn

Auteurs

Thijs de Rooij (T)

Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.

Jony van Hilst (J)

Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.

Baki Topal (B)

Department of Abdominal Surgery, University Hospitals KU Leuven, Leuven, Belgium.

Koop Bosscha (K)

Department of Surgery, Jeroen Bosch Hospital, Den Bosch, the Netherlands.

David J Brinkman (DJ)

Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
Academic Medical Center, Tytgat Institute for Liver and Intestinal Research, Amsterdam, the Netherlands.

Michael F Gerhards (MF)

Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.

Ignace H de Hingh (IH)

Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.

Tom M Karsten (TM)

Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.

Daan J Lips (DJ)

Department of Surgery, Jeroen Bosch Hospital, Den Bosch, the Netherlands.

Misha D Luyer (MD)

Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.

Hendrik A Marsman (HA)

Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.

L Bengt van Rijssen (LB)

Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.

M Willemijn Steen (MW)

Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.

Olivier R Busch (OR)

Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.

Sebastiaan Festen (S)

Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.

Marc G Besselink (MG)

Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH